Found 60 matching trials
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009) PHASE3 The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Show More Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Learn More & Join Trial
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) PHASE3 This study will compare how safe and effective sacituzumab tirumotecan is v...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Learn More & Join Trial
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) PHASE3 Researchers are looking for new ways to treat people with endometrial cance...
Show More Status
Active Not Recruiting
Location
USA Mitchell Cancer Institute ( Site 4142)
Learn More & Join Trial
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) PHASE1 Researchers are looking for new ways to treat esophageal squamous cell carc...
Show More Location
UPMC Hillman Cancer Center ( Site 1904)
Learn More & Join Trial
The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist NA Melasma is a hyperpigmentary disorder of the skin especially of the face. C...
Show More Location
The second affiliated hospital of Xi'an Jiaotong University
Learn More & Join Trial
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) PHASE2 The main goals are after treatment given before surgery, to measure the num...
Show More Location
Southern Cancer Center (SCC) ( Site 8004)
Learn More & Join Trial
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists PHASE3 The study is a global Phase III, multicenter, randomized, double-blind, pla...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) PHASE3 Researchers are looking for new ways to treat types of breast cancer that a...
Show More Location
Banner MD Anderson Cancer Center ( Site 0066)
Learn More & Join Trial
Dietary Supplement With and Without a Probiotic NA Complex oligosaccharides can alter the gut microbiome by aiding in the grow...
Show More Learn More & Join Trial
A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010) PHASE2 Researchers are looking for new ways to treat certain types of advanced sol...
Show More Location
Multiple Locations
Learn More & Join Trial